Dasatinib promotes muscle differentiation and disrupts normal muscle regeneration

Nanami Ishida1, Tamaki Kurosawa1, Momo Goto1

  • 1Laboratory of Veterinary Pharmacology, Department of Veterinary Medical Sciences, Graduate School of Agriculture and Life Sciences, Tokyo University, 1-1-1 Yayoi, Bunkyo-ku, Tokyo, 113-8657, Japan.

Insights

Dasatinib, used for leukemia, disrupts normal muscle regeneration by altering gene expression in myoblasts and muscle fibers. This tyrosine kinase inhibitor impacts skeletal muscle development and repair processes.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Muscle Physiology

Background:

  • Dasatinib is a second-generation tyrosine kinase inhibitor with a broad target spectrum.
  • Previous research suggests dasatinib may improve athletic performance and affect muscle diseases, but its impact on myoblasts is unknown.

Purpose of the Study:

  • To investigate the effects of dasatinib on skeletal muscle under normal and regenerating conditions.
  • To determine dasatinib's influence on C2C12 myoblast proliferation and fusion.

Main Methods:

  • Utilized C2C12 myoblasts to assess proliferation and fusion.
  • Administered dasatinib to a mouse model with CTX-induced muscle injury.
  • Analyzed gene expression of myogenic-related factors (Myod, Myog, Mymx).

Main Results:

  • Dasatinib suppressed C2C12 myoblast proliferation but promoted fusion.
  • Increased gene expression of myogenic regulatory factors during muscle regeneration.
  • Induced abnormally thin muscle fibers in a mouse model of muscle injury.

Conclusions:

  • Dasatinib alters the gene expression patterns of myogenic regulatory factors during muscle differentiation.
  • The drug disrupts normal skeletal muscle regeneration processes.
  • Consideration of dasatinib's skeletal muscle effects is crucial, especially during regeneration stages.

Related Concept Videos

Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.0K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.1K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.8K